Vesynta is a HealthTech company addressing the inequity in health outcomes caused by “one-size-fits-all” drug dosing.
We optimise therapy safety and effectiveness with our decision support software that offers clinicians personalised dose recommendations for traditionally overlooked patient groups, such as women and children.
We do this by integrating with care records, to match mathematical models with healthcare data for patient-centric dosing insights on-demand.
We are able to leverage data-rich healthcare settings to enhance performance of post-market therapies, building a real-world data model to support drug development.
So, if you have a therapy candidate with challenging safety or efficacy profiles, or would like to re-purpose a therapy to a special population, contact us to see how our tools can help you (hello@vesynta.com).
Company Details
- Employees
- 14
- Founded
- -
- Address
- Innovation Gateway, The London Cancer Hub,united Kingdom
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- https://www.vesynta.com/
- Keywords
- precision medicine, paediatric oncology, anti-microbial care, clinical pharmacology, medicine exposure analysis, therapeutic drug monitoring, digital health, drug repurposing, special patient populations, label optimisation, model informed precision dosing.
- HQ
- Sutton, London, England
Vesynta Questions
Vesynta's website is https://www.vesynta.com/
Vesynta's LinkedIn profile is https://uk.linkedin.com/company/vesynta-ltd
Vesynta has
14 employees.
View email and phone details for 14
employees at Vesynta.
Vesynta's industry is
Software Development
Vesynta's top competitors are
Hephaistos-Pharma,
Newton,
Deeplife,
Vortex Liquid Biopsy Solutions,
Therasonic,
Accession,
Curesponse,
Camlist,
Arcascience,
Magic Genomix.
Vesynta's categories are Software Development
Vesynta's founding year is 2019
